Perceptive Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $158M | Sell |
|
|||||
|
2022
Q2 | $96.3M | Sell |
|
|||||
|
2022
Q1 | $135M | Buy |
|
|||||
|
2021
Q4 | $101M | Sell |
|
|||||
|
2021
Q3 | $112M | Buy |
|
|||||
|
2021
Q2 | $145M | Sell |
|
|||||
|
2021
Q1 | $206M | Sell |
|
|||||
|
2020
Q4 | $246M | Sell |
|
|||||
|
2020
Q3 | $320M | Sell |
|
|||||
|
2020
Q2 | $369M | Sell |
|
|||||
|
2020
Q1 | $310M | Buy |
|
|||||
|
2019
Q4 | $466M | Sell |
|
|||||
|
2019
Q3 | $285M | Buy |
|
|||||
|
2019
Q2 | $304M | Buy |
|
|||||
|
2019
Q1 | $292M | Buy |
|
|||||
|
2018
Q4 | $223M | Buy |
|
|||||
|
2018
Q3 | $196M | Buy |
|
|||||
|
2018
Q2 | $218M | Sell |
|
|||||
|
2018
Q1 | $241M | Buy |
|
|||||
|
2017
Q4 | $192M | Buy |
|
|||||
|
2017
Q3 | $132M | Buy |
|
|||||
|
2017
Q2 | $108M | Buy |
|
|||||
|
2017
Q1 | $142M | Buy |
|
|||||
|
2016
Q4 | $45.2M | Buy |
|
|||||
|
2016
Q3 | $53.8M | Buy |
|
|||||
|
2016
Q2 | $36.6M | Buy |
|
|||||
|
2016
Q1 | $20.6M | Buy |
|
|||||
|
2015
Q4 | $38.4M | Buy |
|
|||||
|
2015
Q3 | $38.9M | Buy |
|